MedTrace Logo

Effect of C-Peptide on Diabetic Peripheral Neuropathy

NCT00278980 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2006-01-19

No results posted yet for this study

Summary

The aim of the study is to investigate the effect of C-peptide administration on nerve function in patients with type 1 diabetes and peripheral sensory neuropathy.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetic Polyneuropathy

Interventions

DRUG

C-peptide

Sponsors & Collaborators

  • Creative Peptides Sweden Inc.

    lead INDUSTRY

Principal Investigators

  • Lisa Juntti-Berggren, MD, PhD · Karolinska University Hospital Solna, Stockholm, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2004-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278980 on ClinicalTrials.gov